IDXX Q1 2023 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q1 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$900M+7.6% YoY

Gross Profit

$543M60.3% margin

Operating Income

$280M31.1% margin

Net Income

$214M23.8% margin

EPS (Diluted)

$2.55

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

$184M

Free Cash Flow

$144M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$2.0B

Stockholders' Equity

$841M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$900M	$837M	+7.6%
Gross Profit	$543M	$499M	+8.9%
Operating Income	$280M	$248M	+12.9%
Net Income	$214M	$194M	+10.4%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$3.0B98%

Reagent Rental Programs

$44M1%

Extended Warranties And Post Contract Support

$15M0%

Instrument Rebate Programs

$3M0%

Geographic Segments

UNITED STATES

$590M66%

EMEA

$176M20%

Asia Pacific

$78M9%

CANADA

$36M4%

Latin America

$19M2%